Hello, your email is unverified. Please confirm for access to all your SPH accounts. RESEND
ISRAELI drugmaker Teva Pharmaceuticals Industries Ltd has agreed to buy the generic-drug business of Allergan plc for about US$40.5 billion in cash and stock, and ended its hostile bid for Mylan NV.
Teva will pay US$33.75 billion in cash and US$6.75 billion worth of shares...
Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
CALL +65 6388 3838 EMAIL email@example.com
OPERATING HOURS (+8 GMT) MON-FRI: 8:30AM-5:30PM
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
[BENGALURU] Office-sharing startup WeWork's China unit has received an additional US$200 million in funding from...
[BENGALURU] Australian shares fell more than 1 per cent on Thursday, as concerns about the global economic recovery...
DESPITE Covid-19 showing no signs of abating in the UK - with the country experiencing a second wave of infections...
SINGAPORE stocks opened lower on Thursday, tracking Wall Street losses. The benchmark Straits Times Index (STI) fell...
[HONG KONG] Hong Kong stocks resumed their downward path Thursday following another big sell-off on Wall Street as...